LICENSE AGREEMENTLicense Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD • New York
This License Agreement (the “Agreement”) is made and entered into as of January 29, 2007, (the “Effective Date”) by and between the Salk Institute for Biological Studies, a nonprofit public benefit corporation organized under the laws of the State of California (“Salk”), and Merrion Research I, Ltd., a corporation organized under the laws of Ireland (“Licensee”).
Dated 23rd November 2004 GROWCORP (G.P.) LIMITED as general partner of and on behalf of EUROPEAN BIOSCIENCE FUND I LIMITED PARTNERSHIP GROWCORP GROUP LIMITED ENTERPRISE IRELAND MERRION BIOPHARMA LIMITED MERRION PHARMACEUTICALS, INC. SHAREHOLDERS...Shareholders Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD • Delaware
Dated 23 December 2003 ELAN CORPORATION, plcAgreement • March 30th, 2007 • Merrion Pharmaceuticals LTD
DATED with effect from 10 April 2006 MERRION PHARMACEUTICALS LIMITED DECLAN RYAN OPTION DEED Deed of Agreement (As amended on 22 November 2006) A & L GOODBODY North Wall Quay Dublin 1Merrion Pharmaceuticals LTD • March 30th, 2007
In connection with a re-organisation of the Merrion Group, the Company has agreed to grant to the Grantee options to subscribe for shares and/or stock in the capital of the Company upon the terms and subject to the conditions set out in this Agreement.
Adaptív Biopharma Limited 25/28 North Wall Quay Dublin 1Merrion Pharmaceuticals LTD • March 30th, 2007
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD • North Carolina
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is effective as of April 1, 2004, (the “Effective Date”) by and between Merrion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Thomas Leonard, Ph.D. (the “Employee”), an individual residing in Wilmington, North Carolina.
Dated 5 February 2004 GIPET II LICENCE AGREEMENT ATHENA NEUROSCIENCES, INC. and ADAPTÍV BIOPHARMA LIMITEDLicence Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD • New York
Adaptiv and Elan have entered into an Asset Purchase Agreement dated 5 February 2004 (the Asset Purchase Agreement), pursuant to which Elan have agreed to sell to Adaptiv, and Adaptiv has agreed to purchase from Elan, certain Assets.
SERVICE AGREEMENTService Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD
SERVICE AGREEMENTService Agreement • March 30th, 2007 • Merrion Pharmaceuticals LTD
This letter (hereinafter the Agreement) sets out the terms of your position as Chief Executive Officer of Merrion Pharmaceuticals, Inc. (the Company):
